Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery

European Journal of Ophthalmology

Volumn 15, Issue 6, 2005, Pages 702-711

  Bodaghi, Bahram ^a   Weber, M E ^b   Arnoux, Y V ^c   Jaulerry, S D ^d   Le Hoang, P ^a   Colin, J ^e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Résidence Ste Anne ^*  (France)

^d CENTRE HOSPITALIER   (France)

^e HÔPITAL PELLEGRIN   (France)

Author keywords

ABAK system; Diclofenac; NSAID; Post cataract inflammation; Preservative free; Thiomersal

Indexed keywords

ANTIBIOTIC AGENT; DICLOABAK; DICLOFENAC; EYE DROPS; FLUORESCEIN; GENTAMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; THIOMERSAL;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CHEMOSIS; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY EYE; EYE EDEMA; EYE INFLAMMATION; EYE PAIN; HUMAN; LENS IMPLANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SLIT LAMP; ULCER; VISUAL ACUITY;

EID: 30444446193     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500608     Document Type: Article

References (32)

1. El-Harazi SM, Feldman RM. Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 2001; 12: 4-8.
2. Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg 1997; 23: 1183-9.
3. Herbort CP, Jauch A, Othenin-Girard P, Tritten JJ, Fsadni M. Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand 2000; 78: 421-4.
4. Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol 1996; 80: 480-5.
5. Araie M, Sawa M, Takase M. Topical flurbiprofen and diclofenac suppress blood-aqueous barrier breakdown in cataract surgery: a fluorophotometric study. Jpn J Ophthalmol 1983; 27: 535-42.
6. Laurell CG, Zetterström C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Br J Ophthalmol 2002; 86: 1380-4.
7. Congdon NG, Schein OD, von Kulajta P, Lubomski LH, Gilbert D, Katz J. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J Cataract Refract Surg 2001; 27: 622-31.
8. Suneja T, Belsito DV. Thimerosal in the detection of clinically relevant allergic contact reactions. J Am Acad Dermatol 2001; 45: 23-7.
9. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980; 25: 15-30.
10. Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998; 17: 419-25.
11. Demco TA, Sutton H, Demco CJ, Raj PS. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. Eur J Ophthalmol 1997; 7: 236-40.
12. Shepherd WF, Fsadni MG, Raj PS. A clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgery. Diclofenac-Gentamicin versus Gentamicin Study Group. Ocul Immunol Inflamm 1998; 6: 13-8.
13. Mester U, Lohmann C, Pleyer U, et al. A comparison of two different formulations of diclofenac sodium 0.1% in the treatment of inflammation following cataract-intraocular lens surgery. Drugs R D 2002; 3: 143-51.
14. Rossetti L, Bellucci R, Cillino S, et al. Efficacy and safety of combined diclofenac 0.1% and gentamicin 0.3% eyedrops after phacoemulsification. J Cataract Refract Surg 1997; 23: 745-9.
15. McKellar MJ, Elder MJ. The early complications of cataract surgery. Is routine review of patients 1 week after cataract extraction necessary? Ophthalmology 2001; 108: 930-5.
16. El-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 1998; 29: 539-44.
17. Othenin-Girard P, Tritten JJ, Pittet N, Herbort C.P. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. J Cataract Refract 1994; 20: 9-12.
18. Roberts CW, Brennan KM. A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 1995; 113: 725-7.
19. Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Jpn J Ophthalmol 2000; 44: 58-67.
20. Kraff MC, Sanders DR, McGuigan L, Raanan MG. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. Arch Ophthalmol 1990; 108: 380-3.
21. Koçak I, Yalvaç IS, Koçak A, et al. Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction. Acta Ophthalmol Scand 1998; 76: 343-5.
22. Arnaud B, Trinquand C. Etude en double-insu sur trois groupes parallèles de deux formulations d'indométhacine à 0.1% et du diclofénac à 0.1% dans la prévention et le contrôle de l'inflammation après chirurgie de la cataracte. J Fr Ophtalmol 1997; 20: 183-8.
23. Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 1998; 105: 1775-9.
24. Papa V, Milazzo G, Santocono M, et al. Naproxen ophthalmic solution to manage inflammation after phacoemulsification. J. Cataract Refract Surg 2002; 28: 321-7.
25. Struck HG, Schafer K, Foja C, Giessler C, Lautenschlager C. [Effect of diclofenac and flurbiprofen on the course of inflammation after cataract extraction]. Ophthalmologe 1994; 91: 482-5.
26. Diestelhorst M, Schmidl B, Konen W, Mester U, Raj PS. Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation. J Cataract Refract Surg 1996; 22: 788-93.
27. Killer HE, Borruat FX, Blumer BK, Herbert CP, Jauch A. Corneal penetration of diclofenac from a fixed combination of diclofenac-gentamicin eyedrops. J Cataract Refract Surg 1998; 24: 1365-970.
28. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108: 936-44.
29. Hsu JK, Johnston WT, Read RW, et al. Histopathology of corneal melting associated with diclofenac use after refractive surgery. J Cataract Refract Surg 2003; 29: 250-6.
30. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin 2002; 42: 1-11.
31. Flach AJ. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Ophthalmol Soc 2000; 107: 1224-6.
32. Chiambaretta F, Creuzot Garcher C, Pilon F, et al. Intérêt d'une nouvelle formulation de diclofenac sans conservateur pour la surface oculaire. J Fr Ophtalmol 2004; 27: 739-44.